Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Rachel Ann Freedman, M.D.

Concepts (304)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Breast Neoplasms1272024212066.130 Why?
Chemotherapy, Adjuvant32202435562.250 Why?
Receptor, erbB-224202226032.140 Why?
Breast Neoplasms, Male720242131.770 Why?
SEER Program24202414441.630 Why?
Antineoplastic Agents, Hormonal10202115361.560 Why?
Mastectomy16202318611.310 Why?
Antineoplastic Combined Chemotherapy Protocols232024118781.290 Why?
Quinolines520227721.030 Why?
Neoplasm Staging322024112440.950 Why?
Survivors11202323810.920 Why?
Health Literacy220234660.890 Why?
Mastectomy, Segmental920249740.790 Why?
Mammography7202224330.770 Why?
Medical Oncology7202123460.770 Why?
Health Knowledge, Attitudes, Practice5201940550.770 Why?
Axilla520246230.770 Why?
Female13420243971920.720 Why?
Healthcare Disparities9202434150.710 Why?
Life Expectancy5202412480.700 Why?
Radiotherapy, Adjuvant7201617910.700 Why?
Aged8720241715040.690 Why?
Self-Help Groups120211940.670 Why?
Brain Neoplasms7202091180.620 Why?
Clinical Trials as Topic10202480540.610 Why?
Neoplasm Metastasis15202149120.590 Why?
Neoplasm Recurrence, Local13202494190.590 Why?
Neoplasms, Second Primary3202410610.550 Why?
Receptors, Estrogen13202422530.550 Why?
Aged, 80 and over412024596290.540 Why?
Humans14620247681660.530 Why?
Antineoplastic Agents112020136760.530 Why?
Receptors, Progesterone8202111600.530 Why?
Patient Selection5202142600.520 Why?
Age Factors182024184120.510 Why?
Carcinoma, Intraductal, Noninfiltrating520249340.500 Why?
Carcinoma, Ductal, Breast6201910990.490 Why?
Interdisciplinary Communication120219370.490 Why?
Patient Participation2202114470.490 Why?
Hormone Replacement Therapy120207570.470 Why?
Breast10202319760.460 Why?
Estrogen Replacement Therapy1202012090.440 Why?
Population Surveillance4201825960.410 Why?
Middle Aged6020242234920.410 Why?
Choice Behavior220168480.400 Why?
Epothilones12011420.380 Why?
Withholding Treatment120156200.370 Why?
Social Support1202121930.370 Why?
Paclitaxel5202217330.360 Why?
Geriatrics320203940.360 Why?
Neoplasms, Hormone-Dependent120134100.360 Why?
United States332024730390.350 Why?
Benzothiazoles120112480.350 Why?
Prognosis162023300100.340 Why?
Geriatric Assessment2202314220.330 Why?
Health Services Accessibility3201955200.320 Why?
Lymph Nodes2201734740.310 Why?
Neoplasms72022223710.310 Why?
Carboplatin220227970.310 Why?
Adult4520242236460.300 Why?
Combined Modality Therapy9202485420.300 Why?
Health Education1201510590.300 Why?
Protein Kinase Inhibitors3202457030.300 Why?
Aminopyridines220225800.290 Why?
Patient Preference120159460.290 Why?
Registries11202383750.280 Why?
Medical History Taking120117790.280 Why?
Tonsillar Neoplasms12007500.280 Why?
Kaplan-Meier Estimate9202465260.280 Why?
Referral and Consultation5202336200.280 Why?
Insurance, Health4201725170.280 Why?
Disease-Free Survival7202168470.270 Why?
Benzimidazoles220228640.270 Why?
Myelodysplastic Syndromes1201613990.270 Why?
Mammaplasty2201712680.260 Why?
Socioeconomic Factors4202078520.260 Why?
Paget's Disease, Mammary22015180.260 Why?
Mass Screening2202154580.250 Why?
Enoxaparin120083910.250 Why?
Genetic Testing1201835910.240 Why?
Hospitals2201638860.240 Why?
Postmenopause3202425180.240 Why?
Tamoxifen420249660.230 Why?
Insurance Coverage3201519460.230 Why?
Survival Rate52019128400.230 Why?
Postpartum Hemorrhage120082750.220 Why?
Cohort Studies142024417540.220 Why?
Carcinoma, Lobular220194800.220 Why?
Drug Administration Schedule4201948600.220 Why?
Cyclophosphamide4202222270.220 Why?
Ketones220211830.210 Why?
Neoadjuvant Therapy3201929070.210 Why?
Furans220211990.210 Why?
Medicare11202468090.210 Why?
Follow-Up Studies92020393480.210 Why?
Peripheral Nervous System Diseases220197160.210 Why?
Lymph Node Excision5202412710.200 Why?
Acupuncture, Ear12022130.200 Why?
Practice Guidelines as Topic5202474540.200 Why?
Sentinel Lymph Node Biopsy420227370.190 Why?
Palliative Care1201736430.190 Why?
California2201514380.180 Why?
Leukemia, Myeloid, Acute1201636260.180 Why?
Piperazines2202425540.180 Why?
Odds Ratio5201796690.180 Why?
Young Adult172024600660.170 Why?
Patient Care320226290.170 Why?
Medical Records2201814100.170 Why?
Retrospective Studies212024817620.160 Why?
Xanthones12019230.160 Why?
Pyridines2202428940.160 Why?
Age Distribution3202428730.160 Why?
Pilot Projects3202287410.160 Why?
Interinstitutional Relations120202350.160 Why?
Treatment Outcome132024653710.150 Why?
Perforin120181670.150 Why?
Obesity22018130900.150 Why?
Premenopause2201310390.150 Why?
Radiotherapy3202415020.140 Why?
Quality of Life72024134900.140 Why?
Receptors, Steroid120171560.140 Why?
Logistic Models42017132900.130 Why?
Medication Systems, Hospital120171540.130 Why?
Nitriles220219800.130 Why?
Epidemiologic Factors12015360.130 Why?
Cognition1201370730.120 Why?
Feasibility Studies3202253150.120 Why?
Interferons120197200.120 Why?
Tissue Distribution1201923000.120 Why?
Eukaryotic Initiation Factor-312015470.120 Why?
Acupuncture Therapy120194860.120 Why?
Proportional Hazards Models62023125430.120 Why?
Craniotomy120197360.120 Why?
Early Detection of Cancer3202232390.120 Why?
Clinical Trials, Phase III as Topic120198790.120 Why?
Lymphohistiocytosis, Hemophagocytic120182710.120 Why?
Lung Neoplasms52024135860.120 Why?
Risk Assessment82024243150.120 Why?
Anthracyclines120162860.120 Why?
Randomized Controlled Trials as Topic32020103990.110 Why?
Minority Health12015790.110 Why?
Incidence62024215380.110 Why?
Risk Factors112024749440.110 Why?
Patient Education as Topic2202123370.110 Why?
Gene Expression Profiling3202095380.110 Why?
Adverse Drug Reaction Reporting Systems120174960.110 Why?
Aftercare120209160.110 Why?
Patients120209080.110 Why?
Eligibility Determination120164210.110 Why?
Fatigue2201815570.100 Why?
Factor Analysis, Statistical1201510010.100 Why?
Neoplasm Invasiveness3201936200.100 Why?
Hormones220218660.100 Why?
Molecular Targeted Therapy1202428300.100 Why?
Decision Support Techniques2202120080.100 Why?
Demography1201716410.100 Why?
Lymphatic Metastasis2201729140.100 Why?
Consensus2202132120.100 Why?
Attitude to Health1202120250.100 Why?
Time Factors72024402180.100 Why?
Physical Fitness120167440.100 Why?
Menopause1202016560.100 Why?
Glioblastoma1200734640.100 Why?
Triazoles120179040.100 Why?
Anticoagulants1200848520.100 Why?
Insurance, Health, Reimbursement120153880.100 Why?
Self Report3201837730.100 Why?
Prospective Studies92024549260.090 Why?
Confidence Intervals2201829230.090 Why?
Administration, Oral1201940300.090 Why?
Dose-Response Relationship, Drug22013107600.090 Why?
Evidence-Based Practice120155000.090 Why?
Multivariate Analysis22015120770.090 Why?
Minority Groups2201612160.090 Why?
Deglutition Disorders120176400.090 Why?
Interferon-gamma1201931600.090 Why?
Health Insurance Portability and Accountability Act120111050.090 Why?
Connecticut120113660.090 Why?
Women's Health1202020820.090 Why?
Resilience, Psychological120188070.090 Why?
Pyrazoles1202120280.090 Why?
Estradiol1201719510.090 Why?
Comorbidity22015105900.090 Why?
Radiation Injuries1201711980.080 Why?
Long-Term Care120136310.080 Why?
Chi-Square Distribution1201534360.080 Why?
Leukemia1201715190.080 Why?
Risk2202096130.080 Why?
Deoxycytidine120138870.080 Why?
Fluorouracil1201316520.070 Why?
Adolescent72021891690.070 Why?
Health Care Surveys1201524340.070 Why?
Guideline Adherence1201822350.070 Why?
Social Class2202120080.070 Why?
Male1520243647190.070 Why?
Survival Analysis32016101010.070 Why?
Decision Making2202139530.070 Why?
Quinazolines1201313730.070 Why?
Medicaid3202028400.070 Why?
Longitudinal Studies32019147830.070 Why?
Infusions, Intravenous1201122300.070 Why?
Databases, Factual3201780800.060 Why?
Anxiety1202146720.060 Why?
Data Collection1201533270.060 Why?
Genomics1202159260.060 Why?
Angiogenesis Inhibitors1201520560.060 Why?
Quality Indicators, Health Care1201518050.060 Why?
Pain1202051000.060 Why?
Radiology1201821040.060 Why?
Educational Status1201225150.060 Why?
Workflow220228600.060 Why?
American Cancer Society12024690.060 Why?
Blood-Brain Barrier1201110340.060 Why?
Internet1201631100.060 Why?
Patient Satisfaction1201634880.050 Why?
Exercise2201959550.050 Why?
Depression2202182300.050 Why?
Insurance Claim Review220177440.050 Why?
Diagnostic Imaging1201735330.050 Why?
Guidelines as Topic2202013970.050 Why?
Polymorphism, Single Nucleotide22020160450.050 Why?
Mitosis1200711780.050 Why?
Prevalence22017158690.050 Why?
Hospitalization22023108400.050 Why?
Case-Control Studies32024222910.050 Why?
National Cancer Institute (U.S.)120223000.050 Why?
Pandemics1202187480.050 Why?
Neoplasms, Radiation-Induced120245420.040 Why?
Aging2201987440.040 Why?
Doxorubicin2201722340.040 Why?
Antidepressive Agents1201229130.040 Why?
Family1201132090.040 Why?
Neuropsychological Tests1201371400.040 Why?
Small Cell Lung Carcinoma120244540.040 Why?
Evidence-Based Medicine1201137060.040 Why?
Clinical Competence1201548580.040 Why?
Nausea120226820.040 Why?
Academic Medical Centers2202027840.040 Why?
Disease Management2202025360.040 Why?
Cesarean Section1200814250.040 Why?
Genes, erbB-2120191620.040 Why?
Vomiting120226550.040 Why?
Frail Elderly120237810.040 Why?
Heartburn12017710.030 Why?
Propensity Score2201619690.030 Why?
Brain22020273600.030 Why?
Cancer Care Facilities120184270.030 Why?
Mediastinum120172720.030 Why?
Research Design2202262110.030 Why?
Drug Prescriptions2201716680.030 Why?
Contract Services12015900.030 Why?
Multicenter Studies as Topic1202017370.030 Why?
Medically Uninsured120208400.030 Why?
Drug Therapy120175040.030 Why?
Amino Acid Substitution1201817430.030 Why?
Hematopoiesis1202320590.030 Why?
Taxoids120176670.030 Why?
Antigen Presentation1201912510.030 Why?
Office Visits120175950.030 Why?
Cell Line, Tumor22020171400.030 Why?
Observer Variation1201826220.030 Why?
Morbidity1201817550.030 Why?
Continuity of Patient Care1201910780.020 Why?
Exercise Therapy120199390.020 Why?
Disease Susceptibility1201817930.020 Why?
Mutation32023302380.020 Why?
Proton Pump Inhibitors120175520.020 Why?
Linear Models1202158840.020 Why?
Colorectal Neoplasms1201169740.020 Why?
Magnetic Resonance Imaging32020367430.020 Why?
Xenograft Model Antitumor Assays1201936110.020 Why?
Reproducibility of Results22021202270.020 Why?
Drug Labeling120122500.020 Why?
Preoperative Care1201922580.020 Why?
Vascular Endothelial Growth Factor A1202035140.020 Why?
Tumor Burden1201519060.020 Why?
Poverty1202127200.020 Why?
Aromatase Inhibitors120125190.020 Why?
Pyrimidines1202130480.020 Why?
Health Personnel1202233850.020 Why?
Prostatic Neoplasms12011111010.020 Why?
Drug Approval120158210.020 Why?
Drug Interactions1201214190.020 Why?
Qualitative Research1201931400.020 Why?
Child, Preschool22021426690.020 Why?
Lymphoma1201718980.020 Why?
Alleles1201868940.020 Why?
Body Composition1201624620.020 Why?
Boston1202093740.020 Why?
Tumor Microenvironment1201939480.020 Why?
Pregnancy12008302560.020 Why?
Immunosuppressive Agents1201842060.020 Why?
United States Food and Drug Administration1201216730.010 Why?
Cell Proliferation12019104740.010 Why?
Cross-Sectional Studies12024263790.010 Why?
Gene Expression Regulation, Neoplastic1201786470.010 Why?
Positron-Emission Tomography1201766690.010 Why?
Predictive Value of Tests12016154540.010 Why?
Infant12019365350.010 Why?
Signal Transduction12019236450.010 Why?
Tomography, X-Ray Computed12018207600.010 Why?
Mice12019820290.010 Why?
Child12019809170.010 Why?
Animals120191692460.000 Why?
Freedman's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (304)
Explore
_
Co-Authors (104)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Physical Neighbors
_
© 2025 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.